Acasă › Limfom › North Carolina › Durham
Studii clinice pentru Limfom în Durham, NC
17 studii pentru Limfom caută participanți în și în jurul orașului Durham (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma
În curs de recrutareFaza 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · La 10 mi distanță
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
În curs de recrutareFaza 2
- Duke University, Durham
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
În curs de recrutareFaza 1/2
- Duke University Medical Center, Durham
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
În curs de recrutareFaza 1/2
- UNC School of Medicine, Division of Hematology, Chapel Hill · La 10 mi distanță
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
În curs de recrutare
- Lineberger Comphrehensive Cancer Center at University of North Carolina, Chapel Hill · La 10 mi distanță
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
În curs de recrutareFaza 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · La 10 mi distanță
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
În curs de recrutareFaza 3
- Duke Cancer Institute, Durham
DALY II USA/ MB-CART2019.1 for DLBCL
În curs de recrutareFaza 2
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
În curs de recrutareFaza 1
- Duke University Medical Center, Durham
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
În curs de recrutare
- North Carolina Basnight Cancer Hospital, Chapel Hill · La 10 mi distanță
Registry of Older Patients With Cancer
În curs de recrutareStudiu observațional
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · La 10 mi distanță
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
În curs de recrutareFaza 1/2
- Duke University Medical Center, Duke Cancer Center, Durham
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
În curs de recrutareFaza 2
- University of North Carolina, Chapel Hill · La 10 mi distanță
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
În curs de recrutare
- Duke Cancer Institute, Durham
Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
În curs de recrutareFaza 1
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · La 10 mi distanță
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
În curs de recrutareStudiu observațional
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · La 10 mi distanță
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
În curs de recrutareFaza 2
- Durham VA Medical Center, Durham, NC, Durham
Studii pentru Limfom în alte orașe
- Houston, TX34 studii
- Boston, MA33 studii
- New York City, NY33 studii
- Washington, DC23 studii
- Baldwin Park, CA21 studii
- Chicago, IL20 studii
- St. Louis, MO15 studii
- Philadelphia, PA15 studii
- Cleveland, OH14 studii
- Edison, NJ12 studii
- Atlanta, GA12 studii
- Seattle, WA12 studii
Alte studii în Durham
- Cancer de sân63 studii
- Cancer (toate tipurile)58 studii
- Cancer pulmonar cu celule non-pătrate39 studii
- Mielom multiplu37 studii
- Cancer metastatic33 studii
- Leucemie mieloasă acută33 studii
- Cancer pulmonar32 studii
- Cancer de prostată32 studii
- Cancer colorectal28 studii
- Leucemie limfatică cronică27 studii
- Cancer ovarian27 studii
- Insuficiență cardiacă26 studii
Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.